Company

Sight Sciences, Inc.

Sight Sciences, Inc. is a medical device company that develops eye treatment devices for glaucoma and dry eye disease.

About

Founded in 2011 by co-founders David Badawi and Paul Badawi and based in California, US, Sight Sciences develops eye treatment devices for glaucoma and dry eye disease. The company has raised a total of USD 108.7 million, with backers including Allegro Investment Fund, KCK Group, MidCap Financial and D1 Capital Partners. It completed its IPO in July 2021 and is listed on Nasdaq under the ticker SGHT. It is at the Series F stage.

6Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in